T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.63B |
| 2 |
Merck
MRK
|
+$865M |
| 3 |
EA
Electronic Arts
EA
|
+$786M |
| 4 |
FRC
First Republic Bank
FRC
|
+$712M |
| 5 |
Intuit
INTU
|
+$692M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$21.7B |
| 2 |
Amazon
AMZN
|
+$1.26B |
| 3 |
NXP Semiconductors
NXPI
|
+$1.23B |
| 4 |
AET
Aetna Inc
AET
|
+$890M |
| 5 |
GE Aerospace
GE
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.33% |
| 2 | Financials | 16.18% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Technology | 13.88% |
| 5 | Communication Services | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PG&E
PCG
$37.5B
| $3.03B | 0.57% |
45,697,033
+216,860
| +0.5% | +$13.8M |
|
|
MRSH
27
Marsh
MRSH
$91B
| $3.03B | 0.57% |
40,947,249
-1,644,398
| -4% | -$118M |
|
28
Tesla
TSLA
$1.31T
| $3.01B | 0.56% |
162,315,405
-16,174,740
| -9% | -$274M |
|
29
O'Reilly Automotive
ORLY
$75.3B
| $2.89B | 0.54% |
160,469,295
-128,475
| -0.1% | -$2.32M |
|
30
Lowe's Companies
LOW
$123B
| $2.78B | 0.52% |
33,820,001
+1,032,800
| +3% | +$79.1M |
|
31
State Street
STT
$51.3B
| $2.78B | 0.52% |
34,884,781
-2,417,237
| -6% | -$192M |
|
32
Becton Dickinson
BDX
$48.9B
| $2.75B | 0.51% |
15,351,735
-330,814
| -2% | -$57.7M |
|
33
Johnson & Johnson
JNJ
$631B
| $2.73B | 0.51% |
21,920,409
+4,228,037
| +24% | +$505M |
|
|
AET
34
DELISTED
Aetna Inc
AET
| $2.73B | 0.51% |
21,373,673
-7,085,290
| -25% | -$890M |
|
|
WBA
35
DELISTED
Walgreens Boots Alliance
WBA
| $2.7B | 0.51% |
32,524,838
-5,651,828
| -15% | -$474M |
|
36
Stryker
SYK
$133B
| $2.61B | 0.49% |
19,830,463
+41,233
| +0.2% | +$5.21M |
|
37
ExxonMobil
XOM
$662B
| $2.59B | 0.48% |
31,556,691
-8,217,463
| -21% | -$687M |
|
|
BNY
38
Bank of New York Mellon
BNY
$108B
| $2.56B | 0.48% |
54,276,553
-3,932,211
| -7% | -$184M |
|
39
Humana
HUM
$46.3B
| $2.55B | 0.48% |
12,354,860
+2,191,221
| +22% | +$453M |
|
40
Vertex Pharmaceuticals
VRTX
$133B
| $2.51B | 0.47% |
22,978,643
+1,118,318
| +5% | +$98.5M |
|
41
Pfizer
PFE
$154B
| $2.51B | 0.47% |
77,246,866
-8,022,937
| -9% | -$253M |
|
42
Comcast
CMCSA
$89.4B
| $2.5B | 0.47% |
66,411,460
-4,123,282
| -6% | -$153M |
|
43
Thermo Fisher Scientific
TMO
$222B
| $2.49B | 0.47% |
16,220,262
-1,007,184
| -6% | -$154M |
|
44
Intercontinental Exchange
ICE
$84.5B
| $2.49B | 0.47% |
41,610,032
-7,429,127
| -15% | -$435M |
|
|
ALXN
45
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.34B | 0.44% |
19,285,738
-1,801,682
| -9% | -$232M |
|
|
RHT
46
DELISTED
Red Hat Inc
RHT
| $2.3B | 0.43% |
26,636,702
+1,014,193
| +4% | +$80.6M |
|
|
AMTD
47
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.27B | 0.43% |
58,403,470
-3,247,597
| -5% | -$138M |
|
48
American Airlines Group
AAL
$9.93B
| $2.26B | 0.42% |
53,436,971
-17,081,448
| -24% | -$773M |
|
49
Biogen
BIIB
$30.6B
| $2.22B | 0.42% |
8,118,191
-600,042
| -7% | -$170M |
|
50
AutoZone
AZO
$50.1B
| $2.19B | 0.41% |
3,029,652
-17,898
| -0.6% | -$13.3M |
|
Similar funds
T. Rowe Price Associates's Q1 2017 Portfolio in Review
As of Q1 2017, T. Rowe Price Associates held 2,648 positions worth $534B, up 6% from $504B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates withdrew a net $29B in Q1 2017, closing 78 positions and reducing 979 holdings. Its most notable exit was Spectra Energy Corp Wi, an estimated $404M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Snap worth $632M.
- T. Rowe Price Associates's largest Q1 2017 buy was Snap: 28,319,977 shares worth $632M.
- T. Rowe Price Associates added most to Apple in Q1 2017, an estimated $2.63B increase.
- T. Rowe Price Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $21.7B.
- T. Rowe Price Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $404M.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $534B portfolio in Q1 2017.
- T. Rowe Price Associates opened 102 new positions and closed 78 in Q1 2017.
- T. Rowe Price Associates's portfolio value rose 6% quarter-over-quarter to $534B.
Based on T. Rowe Price Associates's 13F filing for Q1 2017, filed 15 May 2017.